MYC and cancer: Strikingly, MYC is the top altered gene among such patients, followed by long noncoding RNA (lncRNA) genes from the 8q24 gene desert region that have been shown to cooperate with MYC and to exert protumorigenic functions in breast and other cancers (Fig. 6F; Supplementary Table S1; refs. 68, 69).